AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the initiation of the TheraPb Phase 2 expansion trial (NCT05720130) ...
IT affects one in eight men, and so it seems logical to have a prostate cancer screening programme. And yet, in a pivotal ...
In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how the disease transforms into its most lethal form and identified a promising ...
Prostate cancer is the UK's most common cancer, claiming over 12,000 lives annually due to a lack of early symptoms. Despite ...
Former President Joe Biden’s diagnosis of what his office called an “aggressive” form of prostate cancer on Sunday, May 18, is calling attention to a disease that is diagnosed in hundreds of thousands ...
The prostate-specific antigen (PSA) is an enzyme produced by cells in the prostate. One of its roles is to break down the ...
It recommends that only men with a confirmed genetic risk of prostate cancer should be screened for the disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback